Johnson & Johnson logo

Johnson & Johnson

ARS 3894.50 (+0.5%) Dec 2
P/E:
24.91
P/B:
6.27
Market Cap:
ARS 78.41T ($ 466.45B)
Enterprise V:
ARS 78.06T ($ 464.41B)
Volume:
14.87K
Avg Vol (2M):
4.43K
Also Trade In:
Volume:
14.87K
Market Cap ARS:
78.41T
Market Cap $:
466.45B
PE Ratio:
24.91
Avg Vol (2-Month):
4.43K
Enterprise Value ARS:
78.06T
Enterprise Value $:
464.41B
PB Ratio:
6.27
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States.

Financials (Next Earnings Date:2023-01-25 Est.)

BUE:JNJ's 30-Y Financials

Johnson & Johnson Operating Data

BUE:JNJ's Complete Operating Data
No operating data availabel for Johnson & Johnson.

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ARS) 11,216,339.701
EPS (TTM) (ARS) 167.202
Beta 0
Volatility % 74.67
14-Day RSI 16.31
14-Day ATR (ARS) 440.395975
20-Day SMA (ARS) 6939.175
12-1 Month Momentum % 50.39
52-Week Range (ARS) 3700 - 11758
Shares Outstanding (Mil) 13,072.42

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Johnson & Johnson Filings

Document Form Filing Date
No Filing Data

Johnson & Johnson Analysis

Share your research